COVID-19 drug-induced liver injury: A recent update of the literature
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 drug-induced liver injury: A recent update of the literature
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 28, Issue 45, Pages 6314-6327
Publisher
Baishideng Publishing Group Inc.
Online
2022-12-01
DOI
10.3748/wjg.v28.i45.6314
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COVID-19: Gastrointestinal manifestations, liver injury and recommendations
- (2022) Zulal Ozkurt et al. World Journal of Clinical Cases
- MECHANISM OF SARS-COV-2 INVASION INTO THE LIVER AND HEPATIC INJURY IN PATIENTS WITH COVID-19
- (2022) XiaoTian Zhang et al. Mediterranean Journal of Hematology and Infectious Diseases
- Liver injury after SARS‐CoV ‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome
- (2022) Cumali Efe et al. HEPATOLOGY
- Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations
- (2021) Vikram Thakur et al. Journal of Clinical Medicine
- Liver injury in the era of COVID-19
- (2021) Halina Cichoż-Lach et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Liver and kidney function in patients with Covid‐19 treated with remdesivir
- (2021) Sylvia A. Laar et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Janus kinase (JAK)-inhibitors and coronavirus disease 2019 (Covid-19) outcomes: a systematic review and meta-analysis
- (2021) Ronal Yosua Limen et al. Expert Review of Anti-Infective Therapy
- EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update
- (2021) Annalisa Berzigotti et al. JOURNAL OF HEPATOLOGY
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Liver injury in COVID-19: clinical features and treatment management
- (2021) Dongdong Yu et al. Virology Journal
- Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data
- (2021) Huilin Tang et al. International Journal of Clinical Pharmacy
- Elevated Plasma Fibrinogen Is Associated With Excessive Inflammation and Disease Severity in COVID-19 Patients
- (2021) Jingrui Sui et al. Frontiers in Cellular and Infection Microbiology
- Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
- (2021) Vincent C Marconi et al. Lancet Respiratory Medicine
- COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges
- (2021) Gholam Reza Sivandzadeh et al. World Journal of Clinical Cases
- Drug-induced liver injury and COVID-19: A review for clinical practice
- (2021) Gabriela Xavier Ortiz et al. World Journal of Hepatology
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- “Review article: COVID-19 and liver disease - what we know on 1st May 2020”
- (2020) Isabel Garrido et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Case Report: Hepatotoxicity Associated with the Use of Hydroxychloroquine in a Patient with Novel Coronavirus Disease (COVID-19)
- (2020) Melissa Barreto Falcão et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Current pharmacological treatments for COVID‐19: What's next?
- (2020) Cristina Scavone et al. BRITISH JOURNAL OF PHARMACOLOGY
- Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
- (2020) Brandon Michael Henry et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study
- (2020) N. Lian et al. CLINICAL MICROBIOLOGY AND INFECTION
- Incidence of Adverse Drug Reactions in COVID‐19 Patients in China: An Active Monitoring Study by Hospital Pharmacovigilance System
- (2020) Ji Sun et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
- (2020) Tao Zuo et al. GASTROENTEROLOGY
- "Fast, faster, and fastest: science on the run during COVID-19 drama"—"do not forget the liver"
- (2020) S. K. Sarin Hepatology International
- COVID-19: Unanswered questions on immune response and pathogenesis
- (2020) Enrico Maggi et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- COVID-19: Abnormal liver function tests
- (2020) Qingxian Cai et al. JOURNAL OF HEPATOLOGY
- Liver injury during highly pathogenic human coronavirus infections
- (2020) Ling Xu et al. LIVER INTERNATIONAL
- Clinical characteristics of non‐ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study
- (2020) Hansheng Xie et al. LIVER INTERNATIONAL
- Liver diseases in COVID-19: Etiology, treatment and prognosis
- (2020) Jian Wu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Liver injury in COVID-19: The current evidence
- (2020) Saleh A Alqahtani et al. United European Gastroenterology Journal
- Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
- (2020) Jing Liu et al. EBioMedicine
- Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis
- (2020) Ren Mao et al. Lancet Gastroenterology & Hepatology
- Prolonged presence of SARS-CoV-2 viral RNA in faecal samples
- (2020) Yongjian Wu et al. Lancet Gastroenterology & Hepatology
- Liver injury in COVID-19: management and challenges
- (2020) Chao Zhang et al. Lancet Gastroenterology & Hepatology
- SARS-CoV-2 Infection and the Liver
- (2020) Katie Morgan et al. Pathogens
- Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19
- (2020) Anand V. Kulkarni et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Analysis of Gastrointestinal and Hepatic Manifestations of SARS-CoV-2 Infection in 892 Patients in Queens, NY
- (2020) Samson Ferm et al. Clinical Gastroenterology and Hepatology
- Hepatic consequences of COVID-19 infection. Lapping or biting?
- (2020) Piero Portincasa et al. European Journal of Internal Medicine
- Risk factors in patients with COVID-19 developing severe liver injury during hospitalisation
- (2020) Ke Zhan et al. GUT
- Liver injury in remdesivir-treated COVID-19 patients
- (2020) Rosa Zampino et al. Hepatology International
- Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis
- (2020) Yanyan Wu et al. Hepatology International
- Macrolides and viral infections: focus on azithromycin in COVID-19 pathology
- (2020) Arianna Pani et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparison of the Effects of Low‐Molecular‐Weight Heparin and Fondaparinux on Liver Function in Patients With Pulmonary Embolism
- (2020) Xu Yang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
- (2020) J.M. Molina et al. MEDECINE ET MALADIES INFECTIEUSES
- Extrapulmonary manifestations of COVID-19
- (2020) Aakriti Gupta et al. NATURE MEDICINE
- Clinical characteristics of 82 cases of death from COVID-19
- (2020) Bicheng Zhang et al. PLoS One
- The effect of liver test abnormalities on the prognosis of COVID-19
- (2020) Alpay Medetalibeyoglu et al. Annals of Hepatology
- A systematic review and meta-analysis of the COVID-19 associated liver injury
- (2020) Yu Jun Wong et al. Annals of Hepatology
- COVID 19 and liver: An A–Z literature review
- (2020) Marwa Ibrahim Metawea et al. DIGESTIVE AND LIVER DISEASE
- Low risk of hepatitis B reactivation in patients with severe COVID‐19 who receive immunosuppressive therapy
- (2020) Sergio Rodríguez‐Tajes et al. JOURNAL OF VIRAL HEPATITIS
- Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity
- (2020) Suzanne J. F. Kaptein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Etiology and management of liver injury in patients with COVID-19
- (2020) Rui-Xu Yang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan
- (2020) Hu Zhang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Knowledge about COVID-19 and beliefs about and use of herbal products during the COVID-19 pandemic: A cross-sectional study in Saudi Arabia
- (2020) Hamad S. Alyami et al. SAUDI PHARMACEUTICAL JOURNAL
- Pharmacogenomics of COVID-19 therapies
- (2020) Takuto Takahashi et al. npj Genomic Medicine
- Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective
- (2020) Amr Shaaban Hanafy et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment
- (2020) Fiona Marra et al. DRUGS IN R&D
- Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019
- (2019) Rolf Teschke Frontiers in Pharmacology
- Polygalasaponin F treats mice with pneumonia induced by influenza virus
- (2019) Yi Ye et al. INFLAMMOPHARMACOLOGY
- Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM study
- (2018) Sinem Ezgi Gulmez et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Drug-induced liver injury
- (2016) D. Katarey et al. CLINICAL MEDICINE
- Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
- (2015) Naga Chalasani et al. GASTROENTEROLOGY
- Multiple roles of the coagulation protease cascade during virus infection
- (2014) S. Antoniak et al. BLOOD
- T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro
- (2013) T. Baranovich et al. JOURNAL OF VIROLOGY
- Liver enzyme abnormalities in systemic lupus erythematosus: a focus on toxic hepatitis
- (2009) Minyoung Her et al. RHEUMATOLOGY INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started